TrueMark Investments LLC Acquires 31,924 Shares of The Clorox Company (NYSE:CLX)

TrueMark Investments LLC increased its stake in The Clorox Company (NYSE:CLX) by 1,788.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,709 shares of the company’s stock after acquiring an additional 31,924 shares during the period. Clorox comprises about 1.7% of TrueMark Investments LLC’s holdings, making the stock its 11th largest holding. TrueMark Investments LLC’s holdings in Clorox were worth $5,475,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. lifted its stake in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares during the period. Public Employees Retirement System of Ohio increased its position in Clorox by 26.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock valued at $9,736,000 after buying an additional 12,428 shares in the last quarter. Fifth Third Wealth Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter worth $204,000. Apollon Wealth Management LLC boosted its stake in Clorox by 119.6% in the 4th quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company’s stock worth $546,000 after purchasing an additional 1,832 shares in the last quarter. Finally, Miracle Mile Advisors LLC bought a new stake in shares of Clorox during the fourth quarter valued at approximately $1,566,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

CLX opened at $141.80 on Wednesday. The firm’s 50-day moving average price is $152.23 and its 200-day moving average price is $159.43. The company has a market cap of $17.47 billion, a P/E ratio of 38.74, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm earned $2.16 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.44%. Clorox’s payout ratio is currently 133.33%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CLX. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays raised their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and an average target price of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.